Home / Stocks / Apollo Hospitals Enter. L
APOLLOHOSP

Apollo Hospitals Enter. L Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹8,738.0

Change

-83.0 (-0.94%)

Open

₹8,777.0

Prev. Close

₹8,821.0

Day High

₹8,810.0

Day Low

₹8,690.0

Volume Analysis

Traded

317,366

Delivered

166,143

Delivery %

52.35%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (1)

  • •Strong return on equity (21.5%)

Weaknesses (1)

  • •Promoter holding is falling

Opportunities (1)

  • •Strong 3-year EPS growth (33.3%)

Threats (1)

  • •FII holding has been falling

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹8,922.0 ₹8,866.0 ₹8,802.0 ₹8,746.0 ₹8,682.0 ₹8,626.0 ₹8,562.0
Fibonacci ₹8,866.0 ₹8,820.16 ₹8,791.84 ₹8,746.0 ₹8,700.16 ₹8,671.84 ₹8,626.0
Camarilla ₹8,771.0 ₹8,760.0 ₹8,749.0 ₹8,746.0 ₹8,727.0 ₹8,716.0 ₹8,705.0

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

+22.87%

1 Week

+2.62%

1 Month

+14.97%

3 Months

+0.52%

6 Months

+4.49%

1 Year

+17.72%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹1,497.44

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

20.06%

Net margin 8.46% × asset turnover 1.04x × equity multiplier 2.28x

Company Overview

Sector

Healthcare

Market Cap

₹125,893 Cr

P/E (TTM)

55.6

ROE

21.5%

Book Value

₹738.0

Face Value

₹5.0

Source: Screener.in (Consolidated figures) — data as of 18 Nov 2026. Not investment advice.

TopFund Analysis

Apollo Hospitals Enter. L holds up reasonably well on TopFund's composite fundamentals check within the Healthcare sector, at 66/100. The strongest factor is Growth (92/100), while Valuation (1/100) is the weakest area to weigh before deciding. Notably: Strong return on equity (21.5%); promoter holding is falling. FII holding has been falling.

TopFund Score — Fundamentals Quality

66/100 — Good

Data confidence: 80/100 (High Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

72

Growth

92

Valuation

1

Cash Flow

73

Corporate Governance

48

Momentum

78

Institutional Ownership

70

Business Quality

70

Risk & Volatility

81

Liquidity

82

From Screener.in

  • +Company has delivered good profit growth of 76.8% CAGR over last 5 years
  • +Company has been maintaining a healthy dividend payout of 17.7%
  • −Stock is trading at 11.8 times its book value
  • −Company might be capitalizing the interest cost

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Apollo Hospitals posted transcript of Q2 FY27 earnings call for results ended September 30, 2026.

Audio recording of analyst call on Q2 FY2027 results posted on company website.

Apollo Hospitals released its Q2 FY27 and H1 FY27 investor presentation and financial results.

Board approved Q2 FY27 results; Dr. Madhu Sasidhar exits Nov 14, and AHLL completed Cloudnine divestment.

Apollo Hospitals approved Q2 FY27 results; CEO Madhu Sasidhar exits Nov 14, AHLL completed Cloudnine divestment Nov 3.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales + 4,847 4,851 4,944 5,086 5,589 5,527 5,592 5,842 6,189 6,477 6,606 6,932 7,615
Expenses + 4,219 4,237 4,303 4,410 4,774 4,765 4,822 4,990 5,264 5,512 5,594 5,855 6,424
Operating Profit 628 614 640 675 816 762 770 852 924 965 1,011 1,077 1,191
OPM % 13.0% 13.0% 13.0% 13.0% 15.0% 14.0% 14.0% 15.0% 15.0% 15.0% 15.0% 16.0% 16.0%
Other Income + 26 29 37 49 44 69 72 54 54 48 54 52 58
Interest 111 113 119 116 118 110 115 108 99 113 119 108 114
Depreciation 163 167 190 177 184 185 211 215 205 219 224 222 230
Profit before tax 379 363 368 430 557 536 516 583 675 682 722 799 904
Tax % 34.0% 30.0% 30.0% 27.0% 29.0% 29.0% 20.0% 24.0% 27.0% 24.0% 24.0% 24.0% 27.0%
Net Profit + 249 254 258 316 396 379 414 441 494 516 551 610 660
EPS in Rs 16 17 18 21 26 26 27 30 33 35 37 40 44
Raw PDF — — — — — — — — — — — — —
YoY Sales growth 14 14 15 15 15 14 13 15 11 17 18 19 23

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 5,129 6,150 7,256 8,243 9,617 11,247 10,560 14,663 16,612 19,059 21,794 25,228 27,630
Expenses + 4,392 5,465 6,522 7,442 8,548 9,656 9,420 12,474 14,548 16,665 18,761 21,449 23,386
Operating Profit 737 684 734 801 1,070 1,591 1,140 2,189 2,065 2,394 3,033 3,779 4,244
OPM % 14.0% 11.0% 10.0% 10.0% 11.0% 14.0% 11.0% 15.0% 12.0% 13.0% 14.0% 15.0% 15.0%
Other Income + 47 92 60 24 26 222 103 368 75 123 222 207 213
Interest 118 180 257 295 327 533 449 379 381 449 458 450 454
Depreciation 212 264 314 359 396 620 573 601 615 687 758 876 896
Profit before tax 455 332 222 171 373 660 221 1,578 1,144 1,380 2,039 2,661 3,107
Tax % 29.0% 29.0% 41.0% 65.0% 47.0% 34.0% 38.0% 30.0% 22.0% 32.0% 26.0% 25.0% —
Net Profit + 335 235 131 60 200 432 137 1,108 844 935 1,505 2,003 2,338
EPS in Rs 24 17 16 8 17 33 10 73 57 63 101 135 156
Dividend Payout % 24.0% 35.0% 38.0% 59.0% 35.0% 18.0% 29.0% 16.0% 26.0% 26.0% 13.0% 15.0% —
Sales growth 18 20 18 14 17 17 -6 39 13 15 14 16 19

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Reserves 3,102 3,262 3,244 3,182 3,264 3,270 4,531 5,551 6,126 6,864 8,140 9,408 10,532
Borrowings + 1,992 2,834 3,125 3,427 3,673 3,596 4,160 4,068 4,332 5,333 7,864 8,493 8,149
Other Liabilities + 1,296 1,195 1,665 1,917 2,159 4,354 2,629 3,570 3,886 4,474 4,568 4,210 5,469
Total Liabilities 6,459 7,360 8,103 8,596 9,166 11,289 11,392 13,261 14,416 16,742 20,644 22,183 24,222
Fixed Assets + 3,244 3,997 4,591 4,773 4,982 7,432 6,778 8,296 8,520 9,664 10,988 12,272 12,246
CWIP 533 562 347 712 822 236 234 46 610 873 921 1,032 1,494
Investments 311 352 406 352 462 434 1,343 816 574 986 2,487 2,179 2,192
Other Assets + 2,372 2,448 2,759 2,759 2,901 3,187 3,037 4,104 4,712 5,219 6,248 6,700 8,291
Total Assets 6,459 7,360 8,103 8,596 9,166 11,289 11,392 13,261 14,416 16,742 20,644 22,183 24,222
Equity Capital 70 70 70 70 70 70 72 72 72 72 72 72 72

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 470 597 623 537 905 1,293 1,265 1,696 1,377 1,920 2,136 2,856
Cash from Investing Activity + -759 -888 -1,152 -405 -711 -289 -880 -747 -857 -1,537 -3,383 -2,145
Cash from Financing Activity + 392 330 477 -108 -215 -910 -340 -792 -633 -311 1,319 -478
Net Cash Flow 103 39 -52 24 -20 94 44 158 -113 72 73 233
Free Cash Flow -396 -393 -46 -84 233 782 984 1,044 252 785 439 925
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 77 108 103 83 103 100 108 87 85 100 86 92

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 29.33% → 28.02%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Public 5.32% 5.26% 5.38% 5.12% 5.21% 5.41% 5.61% 6.43% 6.71% 6.39% 6.53% 6.49%
Promoters 29.33% 29.33% 29.33% 29.33% 29.33% 29.34% 29.34% 28.02% 28.02% 28.02% 28.02% 28.02%
Government 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23%
FII 46.25% 45.63% 43.92% 45.37% 45.27% 42.74% 43.49% 44.2% 43.54% 42.62% 41.49% 43.19%
DII 18.87% 19.55% 21.13% 19.94% 19.97% 22.29% 21.34% 21.12% 21.5% 22.76% 23.72% 22.07%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Apollo Hospitals Enter. L (this stock) 125,893 55.6 11.86 21.5%
Laurus Labs Limited 125,380 93.6 20.73 18.3%
Zydus Lifesciences Ltd 118,693 26.2 4.27 21.2%
Dr. Reddy S Laboratories 115,092 41.1 2.96 11.2%
Cipla Ltd 112,563 36.2 3.18 11.6%
Mankind Pharma Limited 108,424 46.5 6.16 13.1%
Aurobindo Pharma Ltd 104,215 25.7 2.64 10.1%

Which Mutual Funds Hold Apollo Hospitals Enter. L?

Frequently Asked Questions about Apollo Hospitals Enter. L

Community Sentiment

What are other investors saying about Apollo Hospitals Enter. L?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.